ADA and Fabry disease: [4] Comparable to other lysosomal storage disorders such as Pompe or Gaucher diseases, which are also treated by ERT, classical male FD patients are at high risk for the formation of persisting neutralizing anti-drug antibodies (ADA) against both components of ERT [5,6,7,8].